Top compounds associated with response to TENM3


Feature Type Standardized
Nominal ANOVA
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA BRD-K27224038 CTRPv2 pan-cancer AAC -0.034 0.7
mRNA Irinotecan CCLE pan-cancer AAC -0.024 0.7
mRNA WZ8040 CTRPv2 pan-cancer AAC 0.018 0.7
mRNA Bortezomib GDSC1000 pan-cancer AAC 0.027 0.7
mRNA Zibotentan GDSC1000 pan-cancer AAC 0.016 0.7
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.7
mRNA GDC-0449 GDSC1000 pan-cancer AAC -0.018 0.7
mRNA Imatinib FIMM pan-cancer AAC -0.078 0.7
Download CSV